09 Nov 2018 --- A flash glucose monitoring device made available on prescription across the UK last November is still not available to everyone who may need it, claims a study published in BMJ. According to the study’s findings, about 25 percent of clinical commissioning groups (CCG) do not recommend it to patients, thinking that it is too costly.
